APATINIB

APATINIB Uses, Dosage, Side Effects, Food Interaction and all others data.

APATINIB is under investigation in clinical trial NCT02726854 (Apatinib as Second-line Treatment of Advanced Pancreatic Cancer).

Trade Name APATINIB
Generic Rivoceranib
Rivoceranib Other Names APATINIB, Rivoceranib
Type
Formula C24H23N5O
Weight Average: 397.482
Monoisotopic: 397.190260381
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
APATINIB
APATINIB

Innovators Monograph

You find simplified version here APATINIB

*** Taking medicines without doctor's advice can cause long-term problems.
Share